CNS Solutions
Unparalleled science at scale for your CNS clinical trials
Gain expert clinical guidance and improved data quality to support your CNS clinical studies.
Navigating the Complex Landscape of CNS Clinical Research
Central Nervous System (CNS) diseases are among the most challenging areas of unmet medical need. These disorders manifest at every life stage and vary greatly in severity. Due to fewer early-stage trials and higher attrition rates, CNS clinical research inherently carries greater risk.
Key Challenges in CNS Trials
The foremost challenge is the risk of inconclusive trial results. The complexity of diagnosing and measuring changes in neuropsychiatric disorders demands a partner with deep scientific expertise, robust operational resources, and advanced data insights to identify the right participants for your trial.
Global variations in data collection and reporting add further layers of complexity to CNS clinical research. Collecting and synthesizing this data accurately is critical to your trial’s success. Equally important is the identification and training of hyperspecialized sites capable of executing CNS studies. Sponsors must ensure that appropriate scales, technologies, and review processes are in place to guarantee high-quality data and proper analysis.
Our comprehensive CNS solution offers a modular suite of services leveraging the clinical expertise of WCG scientists and clinicians. Our approach is designed to mitigate risks associated with bias, variability, and human error, addressing the root causes of failed and inconclusive CNS trials.
The CNS Expertise Your Trial Requires
Our solutions for CNS studies draw on our legacy delivering true outcomes for some of the most subjective and complex indications, including psychiatric, neurodegenerative, and pain clinical trials.
Our neuroscience leaders have helped sponsors and CROs reduce the risk of trial failure by supporting the science, data integrity, and approval of vital CNS therapies. From our purpose-built CNS technology to our ability to support global operations with scientific oversight, we have brought together world-renown minds to help you carry out confident decision-making in CNS drug development.
global Alzheimer’s Disease trials supported in the last five years
global Parkinson’s Disease trials supported in the last five years
up to 85% reduction in error rates for endpoints with our eCOA solution
active neurology and psychiatry sites worldwide
A Suite of Five Solutions to Accelerate CNS Studies
Endpoint Selection and Management
eCOA/ePRO Platform
Rater Services
Cognitive Assessments
Study Insight Analytics
Put our CNS Experts on Your Side
Our specialized CNS team brings extensive knowledge and experience to support your trial. We partner with sponsors and CROs to optimize trial design, and manage endpoints and scales, so you can stay at the forefront of CNS drug development.
Our expertise includes:
- More than 481 CNS clinical trials since 2013
- Board-certified neurologists on staff
- Experts in neuroscience clinical research, specifically in neurology, psychiatry, neuropathic pain, and rare diseases
- Global CNS key opinion leaders and site networks
Partner with WCG to navigate the complexities of CNS clinical research and achieve successful outcomes for your trials.
Let’s discuss how you can improve signal detection on your CNS study
A short conversation will help assess your needs and how WCG can assist. To arrange a call with one of our CNS experts, simply fill out this form.
